푸라졸리돈

푸라졸리돈
푸라졸리돈 구조식 이미지
카스 번호:
67-45-8
한글명:
푸라졸리돈
동의어(한글):
푸라졸리돈;퓨라졸리돈
상품명:
Furazolidone
동의어(영문):
Furazolidon;Furoxane;3-(((5-Nitro-2-furanyl)methylene)amino)-2-oxazolidinone;Furoxone;Furazolidine;N-(5-NITRO-2-FURFURYLIDENE)-3-AMINO-2-OXAZOLIDIN-2-ONE;3-[[(5-Nitrofuran-2-yl)methylene]amino]oxazolidin-2-one;Furox;Neftin;NF 180
CBNumber:
CB8452405
분자식:
C8H7N3O5
포뮬러 무게:
225.16
MOL 파일:
67-45-8.mol
MSDS 파일:
SDS

푸라졸리돈 속성

녹는점
254-256°C (dec.)
끓는 점
366.66°C (rough estimate)
밀도
1.5406 (rough estimate)
굴절률
1.7180 (estimate)
인화점
2 °C
저장 조건
Keep in dark place,Sealed in dry,Room Temperature
용해도
포름산: 용해성50mg/mL
산도 계수 (pKa)
-1.98±0.20(Predicted)
물리적 상태
가루
색상
노란색
최대 파장(λmax)
365nm(DMSO)(lit.)
감도
Light Sensitive
Merck
14,4300
BRN
8317414
안정성
안정적인. 타기 쉬운. 강한 산화제와 호환되지 않습니다.
InChIKey
PLHJDBGFXBMTGZ-UITAMQMPSA-N
IARC
3 (Vol. 31, Sup 7) 1987
NIST
Furazolidone(67-45-8)
EPA
Furazolidone (67-45-8)
안전
  • 위험 및 안전 성명
  • 위험 및 사전주의 사항 (GHS)
위험품 표기 Xn,F
위험 카페고리 넘버 62-40-36-20/21/22-11-68
안전지침서 36-22-36/37-16
WGK 독일 3
RTECS 번호 RQ3675000
TSCA Yes
HS 번호 29349990
유해 물질 데이터 67-45-8(Hazardous Substances Data)
기존화학 물질 KE-25992
그림문자(GHS): GHS hazard pictograms
신호 어: Warning
유해·위험 문구:
암호 유해·위험 문구 위험 등급 범주 신호 어 그림 문자 P- 코드
H361 태아 또는 생식능력에 손상을 일으킬 것으로 의심됨 생식독성 물질 구분 2 경고 P201, P202, P281, P308+P313, P405,P501
예방조치문구:
P280 보호장갑/보호의/보안경/안면보호구를 착용하시오.
NFPA 704
1
0 0

푸라졸리돈 C화학적 특성, 용도, 생산

개요

Furazolidone belongs to the group of nitro furans. This antimicrobal (antibacterial and antiprotozoal) agent is used in veterinary medicine both topically and orally, particularly in animal feed. Reactions have been reported in workers exposed to it by contact with animal feed. Cross reactions with other nitrofuran derivatives are rare.

화학적 성질

solid

용도

The minimum inhibitory concentration of furazolidone was assessed to study the nonreplicating persistence of M. tuberculosis in aerobic and anaerobic conditions using luminescence-based low-oxygen-recovery assay.

정의

ChEBI: A member of the class of oxazolidines that is 1,3-oxazolidin-2-one in which the hydrogen attached to the nitrogen is replaced by an N-{[(5-nitro-2-furyl)methylene]amino} group. It has antibacterial and antiprotozoal properties, and is us d in the treatment of giardiasis and cholera.

World Health Organization (WHO)

Furazolidone, a nitrofuran derivative with antibacterial and antiprotozoal activity, was introduced in 1954. In the 1970s it was shown to have a carcinogenic potential following long-term administration to experimental animals. However, the relevance of this to short-term therapy in man has not been established. The risk-benefit assessment varies and furazolidone remains widely available in many countries for the treatment of diarrhoea and enteritis.

Antimicrobial activity

It is active against a wide range of enteric pathogens, including Salmonella enterica, Shigella spp., enterotoxigenic Escherichia coli, Campylobacter jejuni, Aeromonas hydrophila, Plesiomonas shigelloides, Vibrio cholerae and V. parahaemolyticus. Yersinia enterocolitica is intrinsically resistant. Furazolidone is also active against the protozoa Giardia lamblia and Trichomonas vaginalis.

원료

Acquired resistance has been observed in V. cholerae O1 and O139, S. enterica serotypes Typhi and Enteritidis, A. hydrophila and Shigella spp. Such resistance may be transferable, and there is cross-resistance with nitrofurantoin. Many of these reports come from the Indian subcontinent, where furazolidone is used widely for treating diarrheal diseases.

일반 설명

Furazolidone is an effective antiprotozoal and antibacterial agent.

위험도

A questionable carcinogen, use has been restricted.

Pharmaceutical Applications

A non-ionic synthetic compound, available for oral use only. It is poorly soluble in water (40 mg/L) and ethanol (90 mg/L), but dissolves well in dimethylformamide (10 g/L). It decomposes in the presence of alkali.

색상 색인 번호

Furazolidone belongs to the group of nitrofurans. This antimicrobial (antibacterial and antiprotozoal) agent is used in veterinary medicine both topically and orally, particularly in animal feed. Reactions are reported in workers exposed to it in animal feeds. Cross-reactions with other nitrofuran derivatives are rare.

Pharmacokinetics

There is substantial absorption (65–70%) after oral administration, but the drug is heavily metabolized, so that only about 5% of the material excreted is microbiologically active. A dose of 5 mg/kg achieves a maximum plasma concentration of around 1 mg/L. Protein binding is about 30%. Intact drug can be found in various body fluids in concentrations approximating to the minimum inhibitory concentration (MIC) for various intestinal pathogens. Less than 1% of the drug is excreted into urine.

Clinical Use

Furazolidone is used in gastrointestinal infections and vaginitis. It is mainly used in developing countries to treat diarrheal diseases of varying etiology, but it is not the drug of choice if a specific pathogen has been identified. Use as a secondline agent in giardiasis and as part of multidrug regimens in Helicobacter infection has been advocated.

부작용

Most reported side effects are mild and only rarely cause discontinuation of treatment. Nausea and vomiting are experienced by around 8% of patients. Other adverse events include neurological reactions (mainly headache; 1.3% of patients), ‘systemic’ reactions such as fever and malaise (0.6%) and skin rashes (0.54%). Administration of furazolidone may give rise to inhibition of monoamine oxidase, and disulfiram-like reactions have been reported.

Safety Profile

Poison by ingestion and intraperitoneal routes. Human systemic effects by ingestion: dyspnea, respiratory depression, and eosinophilta. Experimental reproductive effects. Human mutation data reported. Questionable carcinogen. When heated to decomposition it emits toxic fumes of NOx.

푸라졸리돈 준비 용품 및 원자재

원자재

준비 용품


푸라졸리돈 공급 업체

글로벌( 488)공급 업체
공급자 전화 이메일 국가 제품 수 이점
Hefei TNJ Chemical Industry Co.,Ltd.
0551-65418684 +8618949823763
sales@tnjchem.com China 25363 58
Siyang Liaoning Biochemical Products Co. Ltd
+86-15221114306; +8615221114306
2594582574@qq.com China 574 58
Hebei Mojin Biotechnology Co., Ltd
+8613288715578
sales@hbmojin.com China 12456 58
Zibo Shiji Zhonglian Medical Technology Co., Ltd.
15069388126 15069388126
sales@sjzlpharm.com China 61 58
Nantong Guangyuan Chemicl Co,Ltd
+undefined17712220823
admin@guyunchem.com China 616 58
ARCTIC EXPORTS INC
+1-3026880818 +1-3026880818
ARCTICEXPORTSINC@GMAIL.COM Canada 68 58
Henan Tianfu Chemical Co.,Ltd.
+86-0371-55170693 +86-19937530512
info@tianfuchem.com China 21691 55
Hangzhou FandaChem Co.,Ltd.
008657128800458; +8615858145714
fandachem@gmail.com China 9348 55
Shanghai Yingrui Biopharma Co., Ltd.
+86-21-33585366 - 03@
sales03@shyrchem.com CHINA 738 60
Hubei XinRunde Chemical Co., Ltd.
+8615102730682
bruce@xrdchem.cn CHINA 566 55

푸라졸리돈 관련 검색:

Copyright 2019 © ChemicalBook. All rights reserved